These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7140679)

  • 1. In vivo and in vitro genotoxicity of three antihypertensive hydrazine derivatives (hydralazine, dihydralazine, and endralazine).
    de Flora S; Zanacchi P; Bennicelli C; Camoirano A; Cavanna M; Sciabà L; Cajelli E; Faggin P; Brambilla G
    Environ Mutagen; 1982; 4(5):605-19. PubMed ID: 7140679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity of the antihypertensive drugs hydralazine and dihydralazine.
    Williams GM; Mazue G; McQueen CA; Shimada T
    Science; 1980 Oct; 210(4467):329-30. PubMed ID: 7423193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mutagenic activity of hydralazine and dihydralazine in Salmonella typhimurium strains differing in expression of antioxidant genes.
    Chłopkiewicz B
    Toxicol Lett; 1999 Nov; 110(3):203-7. PubMed ID: 10597029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of metabolic activation on the induction of micronuclei by antihypertensive drugs in L929 cells.
    Chłopkiewicz B
    Arch Toxicol; 2001 Feb; 74(12):794-8. PubMed ID: 11305783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxic activity of five antidepressant hydrazines in a battery of in vivo and in vitro short-term tests.
    Brambilla G; Cavanna M; Faggin P; Pino A; Robbiano L; Bennicelli C; Zanacchi P; Camoirano A; De Flora S
    J Toxicol Environ Health; 1982 Feb; 9(2):287-303. PubMed ID: 7042990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of phenacetin genotoxicity using in vitro and in vivo test systems.
    De Flora S; Russo P; Pala M; Fassina G; Zunino A; Bennicelli C; Zanacchi P; Camoirano A; Parodi S
    J Toxicol Environ Health; 1985; 16(3-4):355-77. PubMed ID: 3910846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity of hydrazino-phtalazine antihypertensive drugs assessed by an in vitro micronucleus assay.
    Chłopkiewicz B
    Acta Pol Pharm; 1996; 53(5):361-4. PubMed ID: 9415211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propyldazine is mutagenic in Salmonella typhimurium and Escherichia coli: distinct specificity for strains TA1537 and TA97.
    Glatt H; Oesch F
    Teratog Carcinog Mutagen; 1985; 5(5):339-45. PubMed ID: 2867616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of the arteriolar vasodilators hydralazine, dihydralazine and endralazine in the conscious spontaneously hypertensive rat.
    Struyker-Boudier HA; van Essen H; Smits JF
    Eur J Pharmacol; 1983 Nov; 95(3-4):151-9. PubMed ID: 6653667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic toxicity of several antihypertensive drugs possessing a hydrazine group.
    Kitamura J; Mori H; Sugie S; Kawai K
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):415-22. PubMed ID: 4059657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test.
    De Flora S; Zanacchi P; Camoirano A; Bennicelli C; Badolati GS
    Mutat Res; 1984 May; 133(3):161-98. PubMed ID: 6374443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endralazine, a new peripheral vasodilator--a randomized cross-over trial against dihydralazine.
    Kirch W; Axthelm T
    J Cardiovasc Pharmacol; 1982; 4(4):562-6. PubMed ID: 6181329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
    Parodi S; De Flora S; Cavanna M; Pino A; Robbiano L; Bennicelli C; Brambilla G
    Cancer Res; 1981 Apr; 41(4):1469-82. PubMed ID: 7214329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of mutagenicity and genotoxicity induced by dihydralazine.
    Chłopkiewicz B; Ejchart A; Marczewska J
    Acta Biochim Pol; 1995; 42(3):291-5. PubMed ID: 8588478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of hydralazine induced mutagenicity and genotoxicity.
    Chopkiewicz B; Ejchart A; Marczewska J
    Acta Pol Pharm; 1995; 52(3):219-22. PubMed ID: 8960252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic effects of binazine and hydralazine in vitro and in vivo.
    Chłopkiewicz B; Ejchart A; Marczewska J
    Acta Pol Pharm; 1995; 52(1):31-3. PubMed ID: 8960236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxicity assay of oil dispersants in bacteria (mutation, differential lethality, SOS DNA-repair) and yeast (mitotic crossing-over).
    De Flora S; De Renzi GP; Camoirano A; Astengo M; Basso C; Zanacchi P; Bennicelli C
    Mutat Res; 1985; 158(1-2):19-30. PubMed ID: 3900716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies in the rat on endralazine, a new antihypertensive drug structurally related to hydralazine.
    Oates HF; Stoker LM
    Clin Exp Pharmacol Physiol; 1981; 8(2):133-9. PubMed ID: 7018762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing of hydralazine in in vivo-in vitro hepatocyte assays for UDS and stimulation of replicative DNA synthesis.
    Puri EC; Müller D
    Mutat Res; 1989 Jul; 218(1):13-9. PubMed ID: 2747710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicology and carcinogenesis studies of methylene blue trihydrate (Cas No. 7220-79-3) in F344/N rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 May; (540):1-224. PubMed ID: 18685714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.